PCP
MEDP icon

Perbak Capital Partners’s Medpace MEDP Stock Holding History

Perbak Capital Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,396
Closed -$670K – 149
2026
Q1 		$670K Buy
+1,396
New +$715K 0.17% 142
2025
Q4 		– Sell
-1,228
Closed -$631K – 287
2025
Q3 		$631K Sell
1,228
-698
-36% -$305K 0.11% 201
2025
Q2 		$604K Buy
+1,926
New +$578K 0.14% 156

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Perbak Capital Partners's MEDP Position: Q2 2026 in Review

Perbak Capital Partners sold out of Medpace (MEDP) in Q2 2026, closing a stake of 1,396 shares — an estimated $670K sold.

Perbak Capital Partners first reported a position in MEDP in Q2 2025 and held it in 3 quarters. The position peaked at $670K in Q1 2026. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Perbak Capital Partners reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 1,396 Medpace shares in Q2 2026, an estimated $670K.
  • Perbak Capital Partners first reported a position in Medpace in Q2 2025 and held it in 3 quarters.
  • Perbak Capital Partners's Medpace position peaked at $670K in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.